Expression and clinical significance of PD-L1, B7-H3, B7-H4 and VISTA in craniopharyngioma
Background Craniopharyngioma (CP) is a common refractory tumor of the central nervous system. However, little is known about the expression and clinical significance of B7 family ligands/receptors in CP patients. Thus, we conducted the present study to address this issue in a cohort of 132 CP cases....
Saved in:
| Main Authors: | Lin Wang, Jianguo Xu, Yuelong Wang, Shasha Zhao, Xin Tang, Liangxue Zhou, Aiping Tong, Jinlong Yang, Jiaojiao Deng, Tingyue Zhou, Zerong Tian, Jinhao Yang, Hongxu Chen |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2020-10-01
|
| Series: | Journal for ImmunoTherapy of Cancer |
| Online Access: | https://jitc.bmj.com/content/8/2/e000406.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
B7 Homolog 4 (B7-H4)-Directed Agents in Oncology Clinical Trials: A Review
by: Meave Phipps, et al.
Published: (2025-04-01) -
Research progress of B7-H3 in malignant tumors
by: Shuaixiang Zhao, et al.
Published: (2025-05-01) -
B7-H3 and Its Role in Antitumor Immunity
by: Martin Loos, et al.
Published: (2010-01-01) -
Enhanced B7-H4 expression in gliomas with low PD-L1 expression identifies super-cold tumors
by: Yan Zhang, et al.
Published: (2020-05-01) -
Novel bispecific antibody-drug conjugate targeting PD-L1 and B7-H3 enhances antitumor efficacy and promotes immune-mediated antitumor responses
by: Hui Yang, et al.
Published: (2024-10-01)